7th European Advanced Course in Clinical Tuberculosis

Thursday 22 August

7th European Advanced Course in Clinical Tuberculosis Rotterdam, the Netherlands,  11-13 November 2019 Venue: LantarenVenster, Otto Reuchlinweg 996, 3072 MD Rotterdam, the Netherlands The 7th European Advanced Course in Clinical […]

FDA approval of BPaL regimen an important breakthrough in TB control

Wednesday 14 August

The US Food & Drug Administration (FDA) today approved pretomanid for the treatment of highly drug-resistant forms of tuberculosis (TB) in a combination regimen known as BPaL. This regimen was […]

ASCENT: Empowering patients through digital technology

Tuesday 23 July

GENEVA/THE HAGUE, The next three and a half years, KNCV Tuberculosis Foundation will lead the innovative ASCENT project, which stands for Adherence Support Coalition to End TB. This brand new […]

Call to Action for awareness on AMR

Thursday 20 June

KNCV Tuberculosis Foundation is one of the civil society organizations that signs the Call to Action for awareness on antimicrobial resistance (AMR) in the Netherlands. Kitty van Weezenbeek, director of […]

Wolfheze Workshops 2019: inspiring knowledge exchange & concrete steps forward

Tuesday 28 May

KNCV Tuberculosis Foundations can look back at an inspiring edition of the Wolfheze Workshops 2019 (15-17 May). In Scheveningen 160 TB experts from over 40 countries from Western Europe, Eastern […]

Unique gathering of TB and HIV experts in Scheveningen

Wednesday 15 May

Biennial Wolfheze Workshops focuses on alarming tandem of infectious diseases THE HAGUE, 15 May 2019 International experts in the field of tuberculosis (TB) and HIV control meet today in Scheveningen […]

Dutch civil society calls upon increase of Dutch commitment to the Global Fund

Friday 12 April

The Hague – This week, KNCV Tuberculosis Foundation, in cooperation with Aidsfonds and nine other Dutch civil society organisations* called upon the Dutch Minister for Trade and Development Cooperation, Sigrid […]

IT’S TIME … for new TB drugs and treatment regimens for all

Sunday 24 March

THE HAGUE – Today, on World TB Day, the international TB community raises awareness about the deadliest infectious disease in the world. In that context, KNCV Tuberculosis Foundation (KNCV) presents […]

TB remains major public health challenge in European region

Tuesday 19 March

The latest WHO/ECDC report Tuberculosis surveillance and monitoring in Europe 2019 (2017 data) shows that despite an overall decline in numbers of people suffering from TB, the disease remains a […]

Promising results from new drugs and shorter regimen in Kyrgyzstan

Thursday 14 March

The Government of the Kyrgyz Republic and USAID announced major advancements in the fight against the ongoing tuberculosis epidemic in the country. New life-saving treatments are showing promising results only […]

Short Regimen for Preventing TB Found Safe When Co-administered with New First-line HIV Drug

Friday 8 March

New study paves the way for scale-up of TB prevention among people living with HIV, who are dying from TB in large numbers SEATTLE (6 March 2019)—In an important moment […]

Global Fund Director Peter Sands visited KNCV and the Dutch Parliament

Wednesday 6 March

The Hague – Peter Sands, Director of the Global Fund to Fight AIDS, Tuberculosis and Malaria, recently visited the Netherlands. Sands presented the Global Fund Investment Case for the 2020-2022 […]